Shih H N, Hsu R W, Sim F H
Department of Orthopedic Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Republic of China.
World J Surg. 1998 May;22(5):432-7. doi: 10.1007/s002689900411.
Between 1987 and 1994 we followed 22 patients with giant cell tumors involving the long bones. Their average age was 31 years (range 17-50 years). Five patients had grade II tumors and the other 17 grade III lesions. The average volume of lesions after curettage was 231 ml (range 56-450 ml). All of the patients underwent a modified excisional curettage, and the cavity was filled with deep-frozen allogenic corticocancellous bone graft with supplementary fixation. Two patients developed postoperative complications including a superficial wound infection in one case and a traumatic tibial plateau fracture in one case. The overall outcome was good or excellent in 91% of the patients (i.e., 20/22 cases). There was no degenerative joint arthritis and, surprisingly, no instance of tumor recurrence. Allograft infection and fracture were not present. An allogeneic cortical strut with cancellous bone graft can be used safely and is effective for grafting cavitary lesions created after complete removal of the tumor.
1987年至1994年间,我们对22例累及长骨的骨巨细胞瘤患者进行了随访。他们的平均年龄为31岁(范围17 - 50岁)。5例为Ⅱ级肿瘤,其余17例为Ⅲ级病变。刮除术后病变的平均体积为231毫升(范围56 - 450毫升)。所有患者均接受了改良切除刮除术,并用深冻同种异体皮质松质骨移植填充骨腔并辅以固定。2例患者出现术后并发症,1例为表浅伤口感染,1例为创伤性胫骨平台骨折。91%的患者(即20/22例)总体结果良好或优秀。没有发生退行性关节关节炎,而且令人惊讶的是,没有肿瘤复发的情况。未出现同种异体移植物感染和骨折。同种异体皮质支撑松质骨移植可安全使用,对完全切除肿瘤后形成的骨腔病变移植有效。